Advertisement

Chinese Physicians’ Perspectives on the 2017 American College of Cardiology/American Heart Association Hypertension Guideline: A Mobile App-Based Survey

  • Zhao NiEmail author
  • Juan He
  • Ji-Guang Wang
  • Jiepin Cao
  • Qing Yang
  • Bei Wu
  • Ryan Jeffrey Shaw
Original article
  • 32 Downloads

Abstract

Introduction

Hypertension is a leading global risk factor for death and disability. Seeking new ways to prevent and treat hypertension is a priority for scientists and healthcare professionals worldwide. In November 2017, the American College of Cardiology (ACC) and the American Heart Association (AHA) issued a new hypertension guideline shifting the definition of hypertension from 140/90 mm Hg to 130/80 mm Hg for systolic/diastolic blood pressure. This new diagnostic threshold of hypertension has sparked a lively discussion worldwide over whether it should be applied in clinical settings to diagnose and treat hypertension. China, the world’s most populous country, is facing a hypertension crisis. According to the 140/90 mm Hg guideline, China has an estimated 244.5 million population aged ≥ 18 years with hypertension, and another 435.3 million with pre-hypertension. If the new guideline is adopted, the prevalence of hypertension in China would double. This change would significantly impact patients, healthcare professionals, scientists, and policy makers in terms of the delivery of care and needed resources.

Aim

This study aims to investigate whether Chinese physicians will use the 130/80 mm Hg threshold to diagnose hypertension in clinical practice.

Methods

In March 2018, we launched a mobile app-based survey to study 253 Chinese physicians’ perspectives on the ACC/AHA Guideline.

Results

A total of 253 physicians from 21 Chinese provinces completed the survey. Nearly 80% of the participants had already noticed the ACC/AHA guideline change. The proportion of participants who said they would use the new threshold to diagnoses hypertension was 41%, while 59% said they would not use the new threshold. The primary reason for those who said “yes” was that they believed early diagnosis of hypertension can trigger early actions to prevent the increasing blood pressure. For those who said “no”, they argued that their decision was based on the fact that the Chinese Hypertension Prevention Guideline had not yet changed the diagnostic threshold from 140/90 to 130/80 mm Hg.

Conclusions

Different understanding of hypertension prevention and treatment exists among Chinese physicians. It is an emergent need to form an evidence-based authoritative answer to guide Chinese physicians’ future clinical practice.

Keywords

Chinese Physicians Guideline Hypertension 

Notes

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Lim SS, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet Lond Engl. 2012;380(9859):2224–60.CrossRefGoogle Scholar
  2. 2.
    Neal B, et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356(9246):1955–64.CrossRefGoogle Scholar
  3. 3.
    Psaty BM, et al. Health outcomes associated with antihypertensive therapies used as first-line agents—a systematic review and meta-analysis. Jama-J Am Med Assoc. 1997;277(9):739–45.CrossRefGoogle Scholar
  4. 4.
    Wang J-G, Liu L. Global Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: a Perspective From China. Circulation. 2018;137(6):546–8.CrossRefGoogle Scholar
  5. 5.
    Whelton PK, et al. “2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertens. Dallas Tex 1979. 2017.Google Scholar
  6. 6.
    New ACC/AHA High Blood Pressure Guidelines Lower Definition of Hypertension. American College of Cardiology. http://www.acc.org/latest-in-cardiology/articles/2017/11/08/11/47/mon-5pm-bp-guideline-aha-2017. Accessed 24 Nov 2018.
  7. 7.
    Khera R, et al. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. BMJ. 2018;362:k2357.CrossRefGoogle Scholar
  8. 8.
    Crawford C. AAFP Decides to Not Endorse AHA/ACC Hypertension Guideline. https://www.aafp.org/news/health-of-the-public/20171212notendorseaha-accgdlne.html. Accessed: 07 May 2018.
  9. 9.
    Lu J, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–58.CrossRefGoogle Scholar
  10. 10.
    Chobanian AV, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertens Dallas Tex 1979. 2003;42(6):1206–52.Google Scholar
  11. 11.
    Wang Z, et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation. 2018;137:2344–56.CrossRefGoogle Scholar
  12. 12.
    Garies S, et al. Prevalence of hypertension, treatment, and blood pressure targets in Canada Associated With the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines. JAMA Netw Open. 2019;2(3):e190406.CrossRefGoogle Scholar
  13. 13.
    Tocci G, et al. Reclassification of hypertensive outpatients according to New US Guidelines on High Blood Pressure. Am J Hypertens. 2019;32(1):77–87.CrossRefGoogle Scholar
  14. 14.
    Kibria GMA, et al. Estimated change in prevalence of hypertension in Nepal following application of the 2017 ACC/AHA guideline. JAMA Netw Open. 2018;1(3):e180606.CrossRefGoogle Scholar
  15. 15.
    WeChat: number of users 2018. Statista. https://www.statista.com/statistics/255778/number-of-active-wechat-messenger-accounts/. Accessed 14 Jan 2019.
  16. 16.
    Tarrant C, Angell E, Baker R, et al. Developing and piloting the questionnaires (pilots 1 and 2). In: Responsiveness of primary care services: development of a patient-report measure – qualitative study and initial quantitative pilot testing. Health Services and Delivery Research, No. 2.46. Southampton, UK: NIHR Journals Library; 2014.Google Scholar
  17. 17.
    Babbie E. The logic of sampling. In: Howard E, editor. The practice of social research, Chap 7. 10th ed. Belmont: Wadsworth/Thomson; 2004.Google Scholar
  18. 18.
    Sheu S-J, Wei I-L, Chen C-H, Yu S, Tang F-I. Using snowball sampling method with nurses to understand medication administration errors. J Clin Nurs. 2009;18(4):559–69.CrossRefGoogle Scholar
  19. 19.
    Saldana J. The coding manual for qualitative researchers. Thousand Oats: SAGE; 2015.Google Scholar

Copyright information

© Italian Society of Hypertension 2019

Authors and Affiliations

  1. 1.School of NursingDuke UniversityDurhamUSA
  2. 2.West China Hospital, Sichuan UniversityChengduChina
  3. 3.The Shanghai Institute of HypertensionShanghaiChina
  4. 4.Rory Meyers College of NursingNew York UniversityNew YorkUSA
  5. 5.Duke Mobile App GatewayDuke UniversityDurhamUSA
  6. 6.School of Nursing, Health Innovation LabDuke UniversityDurhamUSA
  7. 7.School of Medicine, Center for Applied Genomics and Precision MedicineDuke UniversityDurhamUSA

Personalised recommendations